Review



normal goat serum  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Vector Laboratories normal goat serum
    Normal Goat Serum, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 6396 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Normal+Goat+Serum+Blocking+Solution/pmc13091043-39-0-4
    Average 96 stars, based on 6396 article reviews
    normal goat serum - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Blocking Assay:

    Article Title: Autolysosomal enhancer GHF201 attenuates pathophysiology in a mucopolysaccharidosis type I mouse model.
    Article Snippet: .. The sections were then permeabilized with 0.2% Triton X-100 (Merck) in 1xPBS for 10 min, followed by blocking with 5% goat serum (Vector Laboratories) in 0.1% Triton X100 and 1% BSA (MP Biomedicals) in 1xPBS for 2 h. After blocking, GHF201 attenuates mucopolysaccharidosis type I Kumar et al. https://doi.org/10.26508/lsa.202603750 vol 9 | no 12 | e202603750 20 of 25 sections were washed three times (10 min in each wash) with 1xPBS. ..

    Article Title: Activating systemic inflammation with lipopolysaccharide drives microglia-mediated degradation of perineuronal nets after cervical spinal cord injury in female rats.
    Article Snippet: Activating systemic inflammation with lipopolysaccharide drives microglia-mediated degradation of perineuronal nets after cervical spinal cord injury in female rats Jaison Cucarian, Ram Rakheja, Kale R. Scatterty, Edward Armstrong, Sydney Storvold, Antoinette T. Nguyen, Keith Fenrich, Joshua E. Burda, Steve Lacroix, Karim Fouad PII: S0014-4886(26)00435-8 DOI: https://doi.org/10.1016/j.expneurol.2026.116068 Reference: YEXNR 116068 To appear in: Experimental Neurology Received date: 30 June 2026 Revised date: 1 October 2026 Accepted date: 13 October 2026 Please cite this article as: J. Cucarian, R. Rakheja, K.R.. Scatterty, et al., Activating systemic inflammation with lipopolysaccharide drives microglia-mediated degradation of perineuronal nets after cervical spinal cord injury in female rats, Experimental Neurology (2026), https://doi.org/10.1016/j.expneurol.2026.116068 This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.

    Article Title: Notch-hedgehog antagonism regulates stem cell niche formation through an E2-E3-E3 ubiquitin module.
    Article Snippet: .. After washing, samples were incubated in blocking solution [5% bovine serum albumin (Biobasic, 9048-46- 8) and 5% normal goat serum (Vector Laboratories S-1000) in 0.1% PBST] for 3 h at RT or O/N at 4 °C. ..

    Article Title: Impact of Host α2-Antiplasmin Deficiency on Engraftment and the Morphological Maturation of Transplanted Neural Precursor Cells in the Mouse Brain.
    Article Snippet: .. Immunohistochemistry Floating sections were incubated in a blocking solution consisting of 0.3% Triton X-100 and 10% normal goat serum (Vector Laboratories, Burlingame, CA, U.S.A.) in PBS. .. The sections were then incubated with the following primary Abs in Can Get Signal Immunostain Immunoreaction Enhancer Solution B (Toyobo, Osaka, Japan) for 72 h at 4°C: rabbit anti-DCX Ab (1 : 300; ab18723; Abcam) and rabbit anti-NeuN Ab (1 : 1000; ABN78; Millipore, Temecula, CA, U.S.A.).

    Tissue:

    Article Title: Activating systemic inflammation with lipopolysaccharide drives microglia-mediated degradation of perineuronal nets after cervical spinal cord injury in female rats.
    Article Snippet: Activating systemic inflammation with lipopolysaccharide drives microglia-mediated degradation of perineuronal nets after cervical spinal cord injury in female rats Jaison Cucarian, Ram Rakheja, Kale R. Scatterty, Edward Armstrong, Sydney Storvold, Antoinette T. Nguyen, Keith Fenrich, Joshua E. Burda, Steve Lacroix, Karim Fouad PII: S0014-4886(26)00435-8 DOI: https://doi.org/10.1016/j.expneurol.2026.116068 Reference: YEXNR 116068 To appear in: Experimental Neurology Received date: 30 June 2026 Revised date: 1 October 2026 Accepted date: 13 October 2026 Please cite this article as: J. Cucarian, R. Rakheja, K.R.. Scatterty, et al., Activating systemic inflammation with lipopolysaccharide drives microglia-mediated degradation of perineuronal nets after cervical spinal cord injury in female rats, Experimental Neurology (2026), https://doi.org/10.1016/j.expneurol.2026.116068 This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.

    Article Title: Clusterin is enriched in plaque‐associated astrocytes and localizes to synapses in Alzheimer's disease
    Article Snippet: .. Antibody selection and optimization of brain tissue immunostaining was performed using AD primary auditory cortex cryosections (10 μm) fixed in 4% (w/v) paraformaldehyde (PFA) and permeabilized in PBS with 0.1% (v/v) Triton X‐100 (TxPBS) containing 3% (w/v) BSA and 2% (w/v) normal goat serum (NGS; Vector Labs, #S‐1000). .. Sections were stained with anti‐clusterin mAbs (2D5 or 4C7, 5 μg/ml), and rabbit anti‐glial fibrillary acidic protein (GFAP) polyclonal antibody (pAb; 1:5,000; Dako, #GA524) or 6E10 rabbit anti‐Aβ mAb (1:500; Enzo Life Sciences, #ENZ‐ABS612‐0200) in TxPBS overnight (4°C).

    Transcranial Magnetic Stimulation:

    Article Title: Activating systemic inflammation with lipopolysaccharide drives microglia-mediated degradation of perineuronal nets after cervical spinal cord injury in female rats.
    Article Snippet: Activating systemic inflammation with lipopolysaccharide drives microglia-mediated degradation of perineuronal nets after cervical spinal cord injury in female rats Jaison Cucarian, Ram Rakheja, Kale R. Scatterty, Edward Armstrong, Sydney Storvold, Antoinette T. Nguyen, Keith Fenrich, Joshua E. Burda, Steve Lacroix, Karim Fouad PII: S0014-4886(26)00435-8 DOI: https://doi.org/10.1016/j.expneurol.2026.116068 Reference: YEXNR 116068 To appear in: Experimental Neurology Received date: 30 June 2026 Revised date: 1 October 2026 Accepted date: 13 October 2026 Please cite this article as: J. Cucarian, R. Rakheja, K.R.. Scatterty, et al., Activating systemic inflammation with lipopolysaccharide drives microglia-mediated degradation of perineuronal nets after cervical spinal cord injury in female rats, Experimental Neurology (2026), https://doi.org/10.1016/j.expneurol.2026.116068 This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.

    Selection:

    Article Title: Clusterin is enriched in plaque‐associated astrocytes and localizes to synapses in Alzheimer's disease
    Article Snippet: .. Antibody selection and optimization of brain tissue immunostaining was performed using AD primary auditory cortex cryosections (10 μm) fixed in 4% (w/v) paraformaldehyde (PFA) and permeabilized in PBS with 0.1% (v/v) Triton X‐100 (TxPBS) containing 3% (w/v) BSA and 2% (w/v) normal goat serum (NGS; Vector Labs, #S‐1000). .. Sections were stained with anti‐clusterin mAbs (2D5 or 4C7, 5 μg/ml), and rabbit anti‐glial fibrillary acidic protein (GFAP) polyclonal antibody (pAb; 1:5,000; Dako, #GA524) or 6E10 rabbit anti‐Aβ mAb (1:500; Enzo Life Sciences, #ENZ‐ABS612‐0200) in TxPBS overnight (4°C).

    Immunostaining:

    Article Title: Clusterin is enriched in plaque‐associated astrocytes and localizes to synapses in Alzheimer's disease
    Article Snippet: .. Antibody selection and optimization of brain tissue immunostaining was performed using AD primary auditory cortex cryosections (10 μm) fixed in 4% (w/v) paraformaldehyde (PFA) and permeabilized in PBS with 0.1% (v/v) Triton X‐100 (TxPBS) containing 3% (w/v) BSA and 2% (w/v) normal goat serum (NGS; Vector Labs, #S‐1000). .. Sections were stained with anti‐clusterin mAbs (2D5 or 4C7, 5 μg/ml), and rabbit anti‐glial fibrillary acidic protein (GFAP) polyclonal antibody (pAb; 1:5,000; Dako, #GA524) or 6E10 rabbit anti‐Aβ mAb (1:500; Enzo Life Sciences, #ENZ‐ABS612‐0200) in TxPBS overnight (4°C).

    Next-Generation Sequencing:

    Article Title: Clusterin is enriched in plaque‐associated astrocytes and localizes to synapses in Alzheimer's disease
    Article Snippet: .. Antibody selection and optimization of brain tissue immunostaining was performed using AD primary auditory cortex cryosections (10 μm) fixed in 4% (w/v) paraformaldehyde (PFA) and permeabilized in PBS with 0.1% (v/v) Triton X‐100 (TxPBS) containing 3% (w/v) BSA and 2% (w/v) normal goat serum (NGS; Vector Labs, #S‐1000). .. Sections were stained with anti‐clusterin mAbs (2D5 or 4C7, 5 μg/ml), and rabbit anti‐glial fibrillary acidic protein (GFAP) polyclonal antibody (pAb; 1:5,000; Dako, #GA524) or 6E10 rabbit anti‐Aβ mAb (1:500; Enzo Life Sciences, #ENZ‐ABS612‐0200) in TxPBS overnight (4°C).

    Incubation:

    Article Title: Notch-hedgehog antagonism regulates stem cell niche formation through an E2-E3-E3 ubiquitin module.
    Article Snippet: .. After washing, samples were incubated in blocking solution [5% bovine serum albumin (Biobasic, 9048-46- 8) and 5% normal goat serum (Vector Laboratories S-1000) in 0.1% PBST] for 3 h at RT or O/N at 4 °C. ..

    Article Title: Impact of Host α2-Antiplasmin Deficiency on Engraftment and the Morphological Maturation of Transplanted Neural Precursor Cells in the Mouse Brain.
    Article Snippet: .. Immunohistochemistry Floating sections were incubated in a blocking solution consisting of 0.3% Triton X-100 and 10% normal goat serum (Vector Laboratories, Burlingame, CA, U.S.A.) in PBS. .. The sections were then incubated with the following primary Abs in Can Get Signal Immunostain Immunoreaction Enhancer Solution B (Toyobo, Osaka, Japan) for 72 h at 4°C: rabbit anti-DCX Ab (1 : 300; ab18723; Abcam) and rabbit anti-NeuN Ab (1 : 1000; ABN78; Millipore, Temecula, CA, U.S.A.).

    Immunohistochemistry:

    Article Title: Impact of Host α2-Antiplasmin Deficiency on Engraftment and the Morphological Maturation of Transplanted Neural Precursor Cells in the Mouse Brain.
    Article Snippet: .. Immunohistochemistry Floating sections were incubated in a blocking solution consisting of 0.3% Triton X-100 and 10% normal goat serum (Vector Laboratories, Burlingame, CA, U.S.A.) in PBS. .. The sections were then incubated with the following primary Abs in Can Get Signal Immunostain Immunoreaction Enhancer Solution B (Toyobo, Osaka, Japan) for 72 h at 4°C: rabbit anti-DCX Ab (1 : 300; ab18723; Abcam) and rabbit anti-NeuN Ab (1 : 1000; ABN78; Millipore, Temecula, CA, U.S.A.).



    Similar Products

    96
    Vector Laboratories horse serum nhs
    Horse Serum Nhs, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Normal+Horse+Serum+Blocking+Solution/pm42883015-117-13-16
    Average 96 stars, based on 1 article reviews
    horse serum nhs - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    93
    Proteintech excess blocking solution
    Expression and localization of <t>CA2</t> in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Excess Blocking Solution, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/CA2+Antibody/pmc13686549-242-23-39
    Average 93 stars, based on 1 article reviews
    excess blocking solution - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    96
    Vector Laboratories horse serum
    Expression and localization of <t>CA2</t> in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Horse Serum, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Normal+Horse+Serum+Blocking+Solution/10__1186_slash_s43682___026___00053___7-69-20-24
    Average 96 stars, based on 1 article reviews
    horse serum - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories normal horse serum
    Expression and localization of <t>CA2</t> in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Normal Horse Serum, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Normal+Horse+Serum+Blocking+Solution/pm42882946-73-51-54
    Average 96 stars, based on 1 article reviews
    normal horse serum - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories bloxall
    Expression and localization of <t>CA2</t> in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Bloxall, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/BLOXALL+Endogenous+Peroxidase+and+Alkaline+Phosphatase+Blocking+Solution/pm42880393-60-7-8
    Average 96 stars, based on 1 article reviews
    bloxall - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories normal goat serum
    Expression and localization of <t>CA2</t> in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Normal Goat Serum, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/Normal+Goat+Serum+Blocking+Solution/pm42874699-134-9-12
    Average 96 stars, based on 1 article reviews
    normal goat serum - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories avidin biotin activity
    Expression and localization of <t>CA2</t> in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Avidin Biotin Activity, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/BLOXALL+Endogenous+Peroxidase+and+Alkaline+Phosphatase+Blocking+Solution/pm42867991-662-7-11
    Average 96 stars, based on 1 article reviews
    avidin biotin activity - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Synaptic Systems blocking solution
    Expression and localization of <t>CA2</t> in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.
    Blocking Solution, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/blocking+solution/139+105/pm42867165-143-20-22
    Average 94 stars, based on 1 article reviews
    blocking solution - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Expression and localization of CA2 in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Expression and localization of CA2 in the human placentas and Serum. (A) Heatmap of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (B) Box plot analysis of carbonic anhydrase family expression in placental transcriptomes from normal and preeclamptic pregnancies. (C) MRNA expression level of CA2 in PE and normal placentas detected by RT‐qPCR in the discovery cohort. (D) Representative western blot bands for CA2. (E) Protein expression level of CA2 in PE and normal placentas detected by Western Blot in the discovery cohort. (F) Serum expression level of CA2 in PE and normal women detected by ELISA in the serum validation cohort. (G) Immunohistochemistry method to detect the expression localization of CA2 in placentas from normal and preeclamptic pregnancies. Scale bars: 3 mm (overview), 200 μm (magnified field). All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Expressing, Analysis, Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay, Biomarker Discovery, Immunohistochemistry, Reverse Transcription Polymerase Chain Reaction

    Correlation analysis between CA2 expression and clinical indicators. (A) Correlation of CA2 levels with SBP. (B) Correlation of CA2 levels with DBP. (C) Correlation of CA2 levels with Fetal Weight. (D) Correlation of CA2 levels with APGAR‐1 min. (E) Correlation of CA2 levels with APGAR‐5 min. (F) Correlation of CA2 levels with Proteinuria. (G) Correlation of CA2 levels with maternal blood creatinine levels before delivery. (H) Correlation of CA2 levels with blood urea levels. (I) Correlation of CA2 levels with ALT. (J) Correlation of CA2 levels with AST. (K) Correlation of CA2 levels with PT levels. (L) Correlation of CA2 levels with APTT. (M) Correlation of CA2 levels with platelet levels. Correlation analyses were performed using Pearson's correlation coefficient. ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Correlation analysis between CA2 expression and clinical indicators. (A) Correlation of CA2 levels with SBP. (B) Correlation of CA2 levels with DBP. (C) Correlation of CA2 levels with Fetal Weight. (D) Correlation of CA2 levels with APGAR‐1 min. (E) Correlation of CA2 levels with APGAR‐5 min. (F) Correlation of CA2 levels with Proteinuria. (G) Correlation of CA2 levels with maternal blood creatinine levels before delivery. (H) Correlation of CA2 levels with blood urea levels. (I) Correlation of CA2 levels with ALT. (J) Correlation of CA2 levels with AST. (K) Correlation of CA2 levels with PT levels. (L) Correlation of CA2 levels with APTT. (M) Correlation of CA2 levels with platelet levels. Correlation analyses were performed using Pearson's correlation coefficient. ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Analysis, Expressing

    Preeclampsia modeling and placental CA2 expression in L‐NAME mouse model. (A) Experimental workflow of the L‐NAME‐induced preeclampsia model. (B) Changes in systolic blood pressure in L‐NAME and CONTROL groups. (C, E) Body weights of fetal mice in L‐NAME and CONTROL groups. (D) Placental efficiency of fetal mice in L‐NAME and CONTROL groups. (H) SFLT‐1 levels of mice in L‐NAME and CONTROL groups. (F) The ratio of urinary albumin and creatine of mice in L‐NAME and CONTROL groups. (G, I) Representative renal and placental stained with hematoxylin & eosin (H&E) in L‐NAME and CONTROL groups. Scale bars: 250 μm. (J) Ratio of palcental labyrinth and junction zone of mice in L‐NAME and CONTROL groups. (K) MRNA expression level of placental CA2 in L‐NAME and CONTROL groups detected by RT‐qPCR. (L) Representative western blot bands for CA2. (M) Protein expression level of placental CA2 in L‐NAME and CONTROL groups detected by Western Blot. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Preeclampsia modeling and placental CA2 expression in L‐NAME mouse model. (A) Experimental workflow of the L‐NAME‐induced preeclampsia model. (B) Changes in systolic blood pressure in L‐NAME and CONTROL groups. (C, E) Body weights of fetal mice in L‐NAME and CONTROL groups. (D) Placental efficiency of fetal mice in L‐NAME and CONTROL groups. (H) SFLT‐1 levels of mice in L‐NAME and CONTROL groups. (F) The ratio of urinary albumin and creatine of mice in L‐NAME and CONTROL groups. (G, I) Representative renal and placental stained with hematoxylin & eosin (H&E) in L‐NAME and CONTROL groups. Scale bars: 250 μm. (J) Ratio of palcental labyrinth and junction zone of mice in L‐NAME and CONTROL groups. (K) MRNA expression level of placental CA2 in L‐NAME and CONTROL groups detected by RT‐qPCR. (L) Representative western blot bands for CA2. (M) Protein expression level of placental CA2 in L‐NAME and CONTROL groups detected by Western Blot. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Expressing, Control, Staining, Quantitative RT-PCR, Western Blot, Reverse Transcription Polymerase Chain Reaction

    Effects of CA2 on trophoblast cell function. (A) RT‐qPCR analysis to detect the expression of mRNA level after overexpression of CA2 in HTR‐8/SVneo cells. (B) Representative western blot bands for CA2. (C) Western Blot analysis to detect the expression of protein level after overexpression of CA2 in HTR‐8/SVneo cells. (D) Effect of CA2 overexpression on the proliferative capacity of HTR‐8/SVneo cells. (E) Impact of CA2 overexpression on the migration and invasion abilities of HTR‐8/SVneo cells. (F) Statistical analysis of the Transwell migration and invasion assays. (G) Effect of CA2 overexpression on the apoptotic properties of HTR‐8/SVneo cells. (H) Statistical analysis of the apoptosis assay. pEX‐3‐control: Empty vector control group; pEX‐3‐CA2: CA2 overexpression group. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Effects of CA2 on trophoblast cell function. (A) RT‐qPCR analysis to detect the expression of mRNA level after overexpression of CA2 in HTR‐8/SVneo cells. (B) Representative western blot bands for CA2. (C) Western Blot analysis to detect the expression of protein level after overexpression of CA2 in HTR‐8/SVneo cells. (D) Effect of CA2 overexpression on the proliferative capacity of HTR‐8/SVneo cells. (E) Impact of CA2 overexpression on the migration and invasion abilities of HTR‐8/SVneo cells. (F) Statistical analysis of the Transwell migration and invasion assays. (G) Effect of CA2 overexpression on the apoptotic properties of HTR‐8/SVneo cells. (H) Statistical analysis of the apoptosis assay. pEX‐3‐control: Empty vector control group; pEX‐3‐CA2: CA2 overexpression group. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Cell Function Assay, Quantitative RT-PCR, Analysis, Expressing, Over Expression, Western Blot, Migration, Apoptosis Assay, Control, Plasmid Preparation, Reverse Transcription Polymerase Chain Reaction

    VEGFA overexpression rescues the impaired proliferation, migration and invasion of HTR‐8/SVneo cells induced by CA2 overexpression. (A) Heatmap showing hierarchical clustering of differentially expressed genes between the control and CA2 overexpression groups. (B) Volcano plot of differentially expressed genes. (C) Western Blot analysis of CA2 and VEGFA to detect the protein expression level on the of HTR‐8/SVneo cells in each expremental group. (D) Proliferative capacity analysis of HTR‐8/SVneo cells in the control group、CA2 overexpression group and CA2 and VEGFA co‐overexpression group. (E) Migration and invasion abilities of HTR‐228/SVneo cells in the control group, CA2 overexpression group and CA2 and VEGFA co‐overexpression group. (F) Statistical analysis of the Transwell migration and invasion abilities in the control group, CA2 overexpression group and CA2 and VEGFA co‐overexpression group. pEX‐3‐control 1/2/3: Empty vector control group; pEX‐3‐CA2 1/2/3: CA2 overexpression group; pEX‐3‐control: Empty vector control group; pEX‐3‐ CA2: CA2 overexpression group; pEX‐3‐ CA2+ pEX‐3‐ VEGFA: CA2 and VEGFA co‐overexpression group. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: VEGFA overexpression rescues the impaired proliferation, migration and invasion of HTR‐8/SVneo cells induced by CA2 overexpression. (A) Heatmap showing hierarchical clustering of differentially expressed genes between the control and CA2 overexpression groups. (B) Volcano plot of differentially expressed genes. (C) Western Blot analysis of CA2 and VEGFA to detect the protein expression level on the of HTR‐8/SVneo cells in each expremental group. (D) Proliferative capacity analysis of HTR‐8/SVneo cells in the control group、CA2 overexpression group and CA2 and VEGFA co‐overexpression group. (E) Migration and invasion abilities of HTR‐228/SVneo cells in the control group, CA2 overexpression group and CA2 and VEGFA co‐overexpression group. (F) Statistical analysis of the Transwell migration and invasion abilities in the control group, CA2 overexpression group and CA2 and VEGFA co‐overexpression group. pEX‐3‐control 1/2/3: Empty vector control group; pEX‐3‐CA2 1/2/3: CA2 overexpression group; pEX‐3‐control: Empty vector control group; pEX‐3‐ CA2: CA2 overexpression group; pEX‐3‐ CA2+ pEX‐3‐ VEGFA: CA2 and VEGFA co‐overexpression group. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Over Expression, Migration, Control, Western Blot, Analysis, Expressing, Plasmid Preparation

    HIF‐1α activates the transcription of CA2. (A, B) RT‐qPCR analysis of CA2 and HIF‐1α to detect the expression of mRNA level under hypoxic or normoxia exposure in HTR‐8/Svneo cells. (C) Representative western blot bands. (D, E) Western Blot analysis of CA2 and HIF‐1α to detect the expression of protein level under hypoxic or normoxia exposure in HTR‐8/Svneo cells. (F, G) RT‐qPCR analysis of CA2 and HIF‐1α to detect the expression of mRNA level after overexpression HIF‐1α in HTR‐8/Svneo cells. (H) Representative western blot bands. (I, J) Western Blot analysis of CA2 and HIF‐1α to detect the expression of protein level after overexpression HIF‐1α in HTR‐8/Svneo cells. (K) Luciferase activity of HTR‐8/SVneo cells with or without overexpression HIF‐1α. (L) Luciferase activity of HTR‐8/SVneo cells with or without exposing hypoxic environment. pcDNA3.1‐control: Empty vector control group; pcDNA3.1‐HIF‐1α: HIF‐1α overexpression group; CA2 promoter + Vecter: Plasmid with CA2 promoter + empty vector control group; CA2 promoter + HIF‐1α OE: Plasmid with CA2 promoter + HIF‐1α overexpression group; CA2 promoter + Vecter + hypoxia 12 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 12 h; CA2 promoter + Vecter + hypoxia 24 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 24 h; CA2 promoter + Vecter + hypoxia 36 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 36 h. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: HIF‐1α activates the transcription of CA2. (A, B) RT‐qPCR analysis of CA2 and HIF‐1α to detect the expression of mRNA level under hypoxic or normoxia exposure in HTR‐8/Svneo cells. (C) Representative western blot bands. (D, E) Western Blot analysis of CA2 and HIF‐1α to detect the expression of protein level under hypoxic or normoxia exposure in HTR‐8/Svneo cells. (F, G) RT‐qPCR analysis of CA2 and HIF‐1α to detect the expression of mRNA level after overexpression HIF‐1α in HTR‐8/Svneo cells. (H) Representative western blot bands. (I, J) Western Blot analysis of CA2 and HIF‐1α to detect the expression of protein level after overexpression HIF‐1α in HTR‐8/Svneo cells. (K) Luciferase activity of HTR‐8/SVneo cells with or without overexpression HIF‐1α. (L) Luciferase activity of HTR‐8/SVneo cells with or without exposing hypoxic environment. pcDNA3.1‐control: Empty vector control group; pcDNA3.1‐HIF‐1α: HIF‐1α overexpression group; CA2 promoter + Vecter: Plasmid with CA2 promoter + empty vector control group; CA2 promoter + HIF‐1α OE: Plasmid with CA2 promoter + HIF‐1α overexpression group; CA2 promoter + Vecter + hypoxia 12 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 12 h; CA2 promoter + Vecter + hypoxia 24 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 24 h; CA2 promoter + Vecter + hypoxia 36 h: Plasmid with CA2 promoter + empty vector control group + exposing hypoxic environment 36 h. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Quantitative RT-PCR, Analysis, Expressing, Western Blot, Over Expression, Luciferase, Activity Assay, Control, Plasmid Preparation, Reverse Transcription Polymerase Chain Reaction

    Inhibition of CA2 partially improves outcomes in a L‐NAME‐induced PE mouse model. (A) Experimental workflow for LNP‐NC and LNP‐siCA2 treatment in L‐NAME PE mice. (B) MRNA expression level of placental CA2 in LNP‐NC and LNP‐siCA2 groups detected by RT‐qPCR. (C) Representative immunofluorescence staining of CA2 in LNP‐NC and LNP‐siCA2 groups. Scale bars: 500 μm. (D) Quantitative analysis of mean fluorescence intensity of CA2 immunofluorescence signals n LNP‐NC and LNP‐siCA2 groups. (E) Changes in systolic blood pressure in LNP‐NC and LNP‐siCA2 groups. (F) The ratio of urinary albumin and creatine of mice in LNP‐NC group and LNP‐siCA2 group. (G) Representative renal stained with hematoxylin & eosin (H&E) in LNP‐NC and LNP‐siCA2 groups. (H) SFLT‐1 levels of mice in LNP‐NC and LNP‐siCA2 groups. (I, K) Body weights of fetal mice in LNP‐NC and LNP‐siCA2 groups. (J) Placental efficiency of fetal mice in LNP‐NC group and LNP‐siCA2 group. (L) Representative placental stained with hematoxylin & eosin (H&E) in LNP‐NC and LNP‐siCA2 groups. Scale bars: 250 μm. (M) Ratio of palcental labyrinth and junction zone of mice in LNP‐NC and LNP‐siCA2 groups. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Journal: The FASEB Journal

    Article Title: Hypoxia‐Driven CA2 Promotes Trophoblast Dysfunction in Preeclampsia

    doi: 10.1096/fj.202602024R

    Figure Lengend Snippet: Inhibition of CA2 partially improves outcomes in a L‐NAME‐induced PE mouse model. (A) Experimental workflow for LNP‐NC and LNP‐siCA2 treatment in L‐NAME PE mice. (B) MRNA expression level of placental CA2 in LNP‐NC and LNP‐siCA2 groups detected by RT‐qPCR. (C) Representative immunofluorescence staining of CA2 in LNP‐NC and LNP‐siCA2 groups. Scale bars: 500 μm. (D) Quantitative analysis of mean fluorescence intensity of CA2 immunofluorescence signals n LNP‐NC and LNP‐siCA2 groups. (E) Changes in systolic blood pressure in LNP‐NC and LNP‐siCA2 groups. (F) The ratio of urinary albumin and creatine of mice in LNP‐NC group and LNP‐siCA2 group. (G) Representative renal stained with hematoxylin & eosin (H&E) in LNP‐NC and LNP‐siCA2 groups. (H) SFLT‐1 levels of mice in LNP‐NC and LNP‐siCA2 groups. (I, K) Body weights of fetal mice in LNP‐NC and LNP‐siCA2 groups. (J) Placental efficiency of fetal mice in LNP‐NC group and LNP‐siCA2 group. (L) Representative placental stained with hematoxylin & eosin (H&E) in LNP‐NC and LNP‐siCA2 groups. Scale bars: 250 μm. (M) Ratio of palcental labyrinth and junction zone of mice in LNP‐NC and LNP‐siCA2 groups. All quantitative data are expressed as means ± SD; ns: p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001.

    Article Snippet: After PBS washing, nonspecific binding sites were blocked with 5% bovine serum albumin (BSA) at room temperature for 1 h. Primary antibody incubation: Excess blocking solution was discarded, and sections were incubated with primary antibody targeting CA2 (Cat. 16961‐AP, Proteintech, Wuhan, China) overnight at 4°C in a humidified dark box.

    Techniques: Inhibition, Expressing, Quantitative RT-PCR, Immunofluorescence, Staining, Analysis, Fluorescence, Reverse Transcription Polymerase Chain Reaction